Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy - A CEPAC-TDM biomarker substudy.

Kimberly GeigerMarkus JoergerMax RoesslerKarina HettwerChristoph RitterKirsten SimonSteffen UhligStefan Holdenrieder

Published in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (2024)

Neither soluble PD-1, PD-L1 nor PD-L2 did provide clinical utility for predicting response to chemotherapy and prognosis. Studies on the relevance of PD markers in ICI therapies are warranted.

Keyphrases

patients undergoing
locally advanced
radiation therapy
rectal cancer